"That’s ridiculous and you are wrong the treasur
Post# of 36537
Just trying to get my mind around the potential. We have approx. 700M shares, worth hundreds of millions of dollars in the treasury. When and how does Generex access those funds for acquisitions, drug trials, etc.? In addition don't we have tens (hundreds?) of millions of dollars of losses on the books to offset earnings? Generex has "generated" income from sales of Excellagen, has strengthened it's cancer franchise with cutting edge technologies, has reinvigorated Oralyn with a two puff dosage and Altsulin, has purchased pharmacies, and is in the process of creating a full medical service MSO. I know I didn't mention all the assets, but is this a fairly accurate description of our investment?